The Rosen Law Firm Announces Investigation of Securities Claims Against
Pluristem Therapeutics, Inc. --- PSTI
NEW YORK -- December 21, 2012
The Rosen Law Firm announces that it is investigating potential securities
claims against Pluristem Therapeutics, Inc. (NASDAQ: PSTI) resulting from
allegations that the Company may have issued materially inaccurate statements
to the investing public.
On May 9, 2012, Pluristem issued an announcement touting that its PLX Cells
saved the life of a seven-year old girl. This announcement caused the
Company’s stock to rise more than 13%. On September 19, 2012 the Company
closed a public offering of 8 million shares of common stock - raising over
$32 million. In connection with the offering, the Company issued a Prospectus
that was filed with the SEC on September 14, 2012. The Prospectus mentioned
the medical results for the seven-year old girl as an important clinical
result supporting the effectiveness of PLX cells, omitting that she later
On November 8, 2012, Bloomberg published an article stating that on or before
September 12, 2012 the seven-year old girl had died. This announcement caused
the Company’s stock to fall, over 22%.
The Rosen Law Firm is investigating a securities class action lawsuit on
behalf of Pluristem investors. If you purchased Pluristem securities in the
public offering from Jefferies, Oppenheimer & Co., Needham & Co., or Maxim
Group LLC, you may be able to recover your investment losses. Please visit the
website at http://www.rosenlegal.com to join the prospective action. You may
also contact Phillip Kim or Kevin Chan of The Rosen Law Firm toll free at
866-767-3653 or via e-mail at email@example.com or firstname.lastname@example.org.
The Rosen Law Firm represents investors throughout the globe, concentrating
its practice in securities class actions and shareholder derivative
Attorney Advertising. Prior results do not guarantee a similar outcome.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm P.A.
275 Madison Avenue, 34^th Floor
New York, New York 10016
Tel: (212) 686-1060
Weekends Tel: (917) 562-8616
Toll Free: 1-866-767-3653
Fax: (212) 202-3827
Press spacebar to pause and continue. Press esc to stop.